MENU
+Compare
VERU
Stock ticker: NASDAQ
AS OF
Mar 10, 04:59 PM (EDT)
Price
$0.50
Change
-$0.01 (-1.96%)
Capitalization
75.14M

VERU Veru Forecast, Technical & Fundamental Analysis

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS)... Show more

VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for VERU with price predictions
Mar 04, 2025

Momentum Indicator for VERU turns negative, indicating new downward trend

VERU saw its Momentum Indicator move below the 0 level on February 27, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned negative. In of the 92 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for VERU crossed bearishly below the 50-day moving average on February 05, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VERU entered a downward trend on February 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for VERU just turned positive on February 20, 2025. Looking at past instances where VERU's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VERU advanced for three days, in of 222 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VERU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.822) is normal, around the industry mean (11.742). P/E Ratio (0.000) is within average values for comparable stocks, (66.249). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.790). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (4.448) is also within normal values, averaging (229.516).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VERU is expected to report earnings to rise 1.50% to -6 cents per share on May 07

Veru VERU Stock Earnings Reports
Q1'25
Est.
$-0.06
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.01
Q2'24
Missed
by $0.01
Q1'24
Missed
by $0.01
The last earnings report on February 13 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 911.42K shares outstanding, the current market capitalization sits at 75.14M.
A.I.Advisor
published Dividends

VERU paid dividends on May 07, 2014

Veru VERU Stock Dividends
А dividend of $0.07 per share was paid with a record date of May 07, 2014, and an ex-dividend date of April 28, 2014. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of female condoms

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Household Or Personal Care
Address
2916 North Miami Avenue
Phone
+1 305 509-6897
Employees
189
Web
https://www.verupharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

VERU and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VERU has been loosely correlated with ALLK. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VERU jumps, then ALLK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERU
1D Price
Change %
VERU100%
+3.87%
ALLK - VERU
48%
Loosely correlated
-4.22%
COGT - VERU
32%
Poorly correlated
+2.43%
BMEA - VERU
31%
Poorly correlated
+4.55%
RCUS - VERU
30%
Poorly correlated
-7.71%
RLYB - VERU
30%
Poorly correlated
+4.14%
More